Key Points
- Sc Capital II Sponsor LLC bought 255,000 Nukkleus shares on Nov. 28 at an average price of $10.00, a $2.55 million insider purchase that now leaves the firm holding 255,000 shares.
- The stock opened at $5.95 (market cap ≈ $99.07M), trading well below the $10 buy price and showing extreme volatility with a 1‑year low of $1.34 and high of $78.32.
- Analyst and institutional sentiment is weak: the average analyst rating is Sell (Weiss: sell; Wall Street Zen: upgraded to hold), institutions own about 12.47% of the stock and UBS recently raised its stake to 80,512 shares.
Nukkleus Inc. (NASDAQ:NUKK - Get Free Report) major shareholder Sc Capital Ii Sponsor Llc purchased 255,000 shares of the firm's stock in a transaction on Friday, November 28th. The shares were purchased at an average price of $10.00 per share, for a total transaction of $2,550,000.00. Following the completion of the purchase, the insider directly owned 255,000 shares of the company's stock, valued at $2,550,000. This represents a ∞ increase in their ownership of the stock. The purchase was disclosed in a document filed with the SEC, which can be accessed through this link. Major shareholders that own 10% or more of a company's shares are required to disclose their sales and purchases with the SEC.
Nukkleus Price Performance
Shares of NASDAQ NUKK opened at $5.95 on Tuesday. The company has a market cap of $99.07 million, a price-to-earnings ratio of 0.36 and a beta of -6.74. The stock's 50-day moving average is $7.09 and its two-hundred day moving average is $8.28. Nukkleus Inc. has a 1-year low of $1.34 and a 1-year high of $78.32.
Nukkleus (NASDAQ:NUKK - Get Free Report) last announced its quarterly earnings data on Friday, November 14th. The company reported ($2.02) EPS for the quarter.
Analysts Set New Price Targets
A number of equities research analysts have commented on NUKK shares. Weiss Ratings reissued a "sell (d)" rating on shares of Nukkleus in a research report on Wednesday, October 8th. Wall Street Zen raised Nukkleus from a "sell" rating to a "hold" rating in a report on Sunday, November 23rd. One equities research analyst has rated the stock with a Sell rating, According to MarketBeat, Nukkleus presently has an average rating of "Sell".
Read Our Latest Stock Report on NUKK
Institutional Trading of Nukkleus
Several institutional investors have recently modified their holdings of NUKK. BNP Paribas Financial Markets acquired a new position in shares of Nukkleus in the 2nd quarter valued at $56,000. Ausdal Financial Partners Inc. purchased a new stake in Nukkleus in the third quarter valued at $105,000. XTX Topco Ltd acquired a new position in Nukkleus in the first quarter valued at $125,000. Finally, UBS Group AG grew its holdings in shares of Nukkleus by 23.3% during the third quarter. UBS Group AG now owns 80,512 shares of the company's stock worth $564,000 after purchasing an additional 15,223 shares during the last quarter. Hedge funds and other institutional investors own 12.47% of the company's stock.
About Nukkleus
(
Get Free Report)
Nukkleus Inc, a financial technology company, provides blockchain-enabled technology solutions worldwide. It focuses on providing software and technology solutions for retail foreign exchange trading industry. The company provides transactions platform for dealing and risk management services. It also offers cross-border payment and transactions solutions and blockchain-enabled financial services solutions to institutional investors.
See Also
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
